Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices. | HIV | JAMA Oncology | JAMA Network

Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices. | HIV | JAMA Oncology | JAMA Network

Hepatitis often undiagnosed in new cancer patients

A new study suggests that many hepatitis infections are going undiagnosed in cancer patients. The study looked at more than 3,000 newly diagnosed cancer patients who lived across the U.S. and were screened for hepatitis B, hepatitis C, and HIV. The infection rates were similar to those seen in the general population. But 87 percent of patients with past hepatitis B, 42 percent of those with chronic hepatitis B, and 31 percent of people with hepatitis C infections hadn't been diagnosed. The researchers are currently analyzing the results of a related study looking into whether it's cost-effective to have universal hepatitis and HIV screenings for cancer patients.

Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices

Scott D. Ramsey, MD, PhD¹; Joseph M. Unger, PhD^2,3; Laurence H. Baker, DO⁴; et alRichard F. Little, MD⁵; Rohit Loomba, MD⁶; Jessica P. Hwang, MD, MPH⁷; Rashmi Chugh, MD⁴; Monica A. Konerman, MD⁴; Kathryn Arnold, MS^2,3; Alex R. Menter, MD⁸; Eva Thomas, MD⁹; Ross M. Michels, MD¹⁰; Carla Walker Jorgensen, MD¹⁰; Gary V. Burton, MD¹¹; Nishin A. Bhadkamkar, MD⁷; Dawn L. Hershman, MD¹²

Author Affiliations Article Information